A detailed history of Winslow Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Winslow Capital Management, LLC holds 771,113 shares of LLY stock, worth $614 Million. This represents 2.49% of its overall portfolio holdings.

Number of Shares
771,113
Previous 603,157 27.85%
Holding current value
$614 Million
Previous $546 Million 25.1%
% of portfolio
2.49%
Previous 1.97%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $130 Million - $161 Million
167,956 Added 27.85%
771,113 $683 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $28.3 Million - $35.6 Million
39,109 Added 6.93%
603,157 $546 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $50.3 Million - $67.3 Million
-84,923 Reduced 13.09%
564,048 $439 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $1.1 Million - $1.3 Million
2,094 Added 0.32%
648,971 $378 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $70.2 Million - $96.8 Million
161,509 Added 33.28%
646,877 $347 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $170 Million - $228 Million
485,368 New
485,368 $228 Million
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $319 Million - $413 Million
-1,942,514 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $54.5 Million - $72.2 Million
-417,948 Reduced 17.71%
1,942,514 $328 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $12.1 Million - $14 Million
-82,670 Reduced 3.38%
2,360,462 $349 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $102 Million - $122 Million
745,802 Added 43.94%
2,443,132 $401 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $202 Million - $250 Million
1,697,330 New
1,697,330 $235 Million
Q2 2019

Aug 12, 2019

SELL
$110.79 - $129.32 $193 Million - $225 Million
-1,741,194 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$111.31 - $131.02 $30.3 Million - $35.6 Million
272,003 Added 18.51%
1,741,194 $226 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $156 Million - $174 Million
1,469,191 New
1,469,191 $170 Million
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $11,733 - $13,466
-155 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $159 Million - $187 Million
-2,135,934 Reduced 99.99%
155 $12,000
Q4 2017

Feb 12, 2018

SELL
$81.94 - $87.89 $137 Million - $147 Million
-1,674,453 Reduced 43.94%
2,136,089 $180 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $294 Million - $326 Million
3,810,542
3,810,542 $326 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Winslow Capital Management, LLC Portfolio

Follow Winslow Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Capital Management, LLC with notifications on news.